Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes.
AUTOR(ES)
Crane, L R
RESUMO
Polyriboinosinic-polyribocytidylic acid complexed with poly-l-lysine and carboxymethylcellulose [poly(ICLC)] is a potent interferon inducer when given parenterally to humans. Topical application in animal models has shown beneficial antiviral and clinical effects. In a randomized, double-blinded, placebo-controlled trial of topical poly(ICLC) in recurrent genital herpes simplex virus infection, five clinical and two virological parameters were followed. Fifty-seven men and women, with 78 recurrences of genital herpes, were stratified by sex. No clinical or antiviral differences between poly(ICLC) and placebo groups in either stratum were found. Further analysis of male subgroups by age and size of lesions showed no changes in the rapidity of healing or viral shedding.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181918Documentos Relacionados
- Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.
- Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.
- Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components.
- Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
- Systemic Metabolic Alterations Associated with Repeated Injections of a Modified Polyriboinosinic-Polyribocytidylic Acid Complex
